The overexpression of PD-L1 in cancer cells is correlated with the poor prognosis of patients with advanced non-small cell lung cancer (NSCLC) [7], breast cancer [8], head/neck cancer [9], gastric cancer [10], and prostate cancer [11]. Here, CD274 is linked to cancer.